← back to search

Jan Sjövall

Karolinska Institutet · SE
Area of research
Spectroscopy · Oncology
Research interest
Research interests include Drug Transport and Resistance Mechanisms, Analytical Chemistry and Chromatography, Cholesterol and Lipid Metabolism, and Mass Spectrometry Techniques and Applications.
h-index
87
citations
26,965
works
510
NIH funding
primary concept
email

Recent publications

Bile acid biosynthesis in Smith-Lemli-Opitz syndrome bypassing cholesterol: Potential importance of pathway intermediates
The Journal of Steroid Biochemistry and Molecular Biology 2020cited by 25position: middledoi
Bile Acid Biosynthesis Avoiding Cholesterol
bioRxiv (Cold Spring Harbor Laboratory) 2018cited by 0position: middledoi
Cholestenoic acids regulate motor neuron survival via liver X receptors
Journal of Clinical Investigation 2014cited by 113position: middledoi
Brain endogenous liver X receptor ligands selectively promote midbrain neurogenesis
Nature Chemical Biology 2012cited by 131position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yuqin Wang · Shandong University3 papers (2012–2020)William J. Griffiths · Swansea University3 papers (2012–2020)Cedric Shackleton · University of Birmingham2 papers (2018–2020)Eylan Yutuc · Swansea University2 papers (2018–2020) · 2 papers (2018–2020)Peter T. Clayton · The University of Adelaide2 papers (2018–2020)Rajat Rohatgi · Palo Alto University2 papers (2018–2020)Brian Bigger · University of Manchester2 papers (2018–2020)Hanns–Ulrich Marschall · Sahlgrenska University Hospital2 papers (2018–2020)Peter J. Crick · Swansea University2 papers (2018–2020)Jonas Abdel‐Khalik · Swansea University2 papers (2018–2020) · 2 papers (2018–2020)Andrew A. M. Morris · Swansea University2 papers (2018–2020)Ingemar Björkhem · Karolinska Institutet2 papers (2018–2020)Jan-Åke Gustafsson · Karolinska Institutet1 papers (2012–2012)Karl Bodin · University College London1 papers (2012–2012)Kyle M. Sousa · Loma Linda University1 papers (2012–2012) · 1 papers (2012–2012)Patrik Ernfors · Karolinska Institutet1 papers (2012–2012)Enrique M. Toledo · Novo Nordisk (Denmark)1 papers (2012–2012)